ArticleCancers2024

Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI).

Heejung Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.